Slate Run Pharmaceuticals recalls

Slate Run Pharmaceuticals appears in 3 official U.S. recall notices indexed by RecallRadar, most recently on 2026-03-04.

Company names are normalized from agency data (legal suffixes removed), so related firms may appear under separate pages.

• Eptifibatide Injection, 75 mg/100 mL vial for weight-adjusted bolus dosing, 1x100 mL Single-dose Vial, For Intravenous Use Only, Rx Only, M…
  FDA Drug · Class III · 2026-03-04 · Slate Run Pharmaceuticals
• Cinacalcet Hydrochloride Tablets 60 mg, 30-count bottle, Rx only, Distr. by: Slate Run Pharma., LLC, Columbus, Ohio 43215, Mfg. by: Piramal…
  FDA Drug · Class II · 2025-03-26 · Slate Run Pharmaceuticals
• Cinacalcet Hydrochloride Tablets 30 mg, 30-count bottle, Rx only, Distr. by: Slate Run Pharma., LLC, Columbus, Ohio 43215, Mfg. by: Piramal…
  FDA Drug · Class II · 2025-03-26 · Slate Run Pharmaceuticals